Effects of NSAIDs on proliferation of gastric cancer cells in vitro: possible implication of cyclooxygenase-2 in cancer development
- PMID: 9872498
- DOI: 10.1097/00004836-199800001-00009
Effects of NSAIDs on proliferation of gastric cancer cells in vitro: possible implication of cyclooxygenase-2 in cancer development
Abstract
The roles of cyclooxygenase-2 (COX-2) in the development of gastric cancer are unknown. We investigated the effects of nonsteroidal antiinflammatory drugs (NSAIDs), which are specific and nonspecific inhibitors of COX-2, on proliferation of the gastric cancer cell lines KATOIII, MKN28, and MKN45. The protein level of COX-2 was examined in these cell lines by Western analysis, and mRNA levels of COX-1/2 by Northern analysis. These cell lines expressed comparable levels of COX-1 mRNA. However, mRNA and protein expression of COX-2 in these cell lines was different. MKN45 expressed higher levels of COX-2 mRNA and protein than KATOIII and MKN28. We also examined the effects of NS-398 and indomethacin, specific and nonspecific inhibitors of COX-2, on the increase in cell number and [3H]thymidine uptake of these cell lines. NS-398 and indomethacin suppressed proliferation of MKN45 cells that overexpressed COX-2, although they exerted minimal effects on proliferation of KATOIII and MKN28, which expressed lower levels of COX-2. These results are consistent with the hypothesis that COX-2 is expressed in certain groups of gastric cancers and is related to their cell proliferation. It was proposed that COX-2 plays an important role in development of gastric cancer cells. Furthermore, NSAIDs may exert antiproliferative activity against gastric adenocarcinomas that overexpress COX-2.
Similar articles
-
Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines.Prostaglandins Leukot Essent Fatty Acids. 1996 Sep;55(3):179-83. doi: 10.1016/s0952-3278(96)90095-2. Prostaglandins Leukot Essent Fatty Acids. 1996. PMID: 8931116
-
MAPK (ERK2) kinase--a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth.Life Sci. 2001 Nov 9;69(25-26):3045-54. doi: 10.1016/s0024-3205(01)01411-4. Life Sci. 2001. PMID: 11758830
-
Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.Dig Dis Sci. 1998 Sep;43(9):2003-11. doi: 10.1023/a:1018846912032. Dig Dis Sci. 1998. PMID: 9753266
-
Cyclooxygenase-2 and gastric carcinogenesis.APMIS. 2003 Oct;111(10):915-25. doi: 10.1034/j.1600-0463.2003.1111001.x. APMIS. 2003. PMID: 14616542 Review.
-
Role of cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma.Scand J Gastroenterol Suppl. 2003;(239):87-93. doi: 10.1080/00855920310002753. Scand J Gastroenterol Suppl. 2003. PMID: 14743889 Review.
Cited by
-
Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: A dose-response meta-analysis.Oncotarget. 2017 Jan 17;8(3):4781-4795. doi: 10.18632/oncotarget.13591. Oncotarget. 2017. PMID: 27902474 Free PMC article.
-
Aspirin and risk for gastric cancer: a population-based case-control study in Sweden.Br J Cancer. 2001 Apr 6;84(7):965-8. doi: 10.1054/bjoc.2001.1702. Br J Cancer. 2001. PMID: 11286478 Free PMC article.
-
Identification of novel cyclooxygenase-2-dependent genes in Helicobacter pylori infection in vivo.Mol Cancer. 2009 Mar 24;8:22. doi: 10.1186/1476-4598-8-22. Mol Cancer. 2009. PMID: 19317916 Free PMC article.
-
New NSAID targets and derivatives for colorectal cancer chemoprevention.Recent Results Cancer Res. 2013;191:105-20. doi: 10.1007/978-3-642-30331-9_6. Recent Results Cancer Res. 2013. PMID: 22893202 Free PMC article. Review.
-
Expression of cyclooxygenase-2, p53 and Ki-67 in gastric cancer.J Korean Med Sci. 2006 Oct;21(5):871-6. doi: 10.3346/jkms.2006.21.5.871. J Korean Med Sci. 2006. PMID: 17043422 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous